ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.489,00
-0,60%
S&P 500
5.631,22
0,00%
Dow Jones
40.211,72
0,00%
Euro vs US Dollar
1,09024
0,03%
Bitcoin
63.987,60
-1,33%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) News

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DatumZeitQuelleÜberschriftSymbolFirma
06/03/201922h05PR Newswire (US)Ardelyx Reports Fourth Quarter 2018 Financial Results and Recent HighlightsNASDAQ:ARDXArdelyx Inc
21/02/201914h00PR Newswire (US)Ardelyx to Participate in Leerink Partners 8th Annual Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
19/02/201914h52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARDXArdelyx Inc
14/02/201917h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARDXArdelyx Inc
13/02/201919h47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARDXArdelyx Inc
12/02/201914h25GlobeNewswire Inc.Factors of Influence in 2019, Key Indicators and Opportunity within Park Hotels & Resorts, Planet Fitness, Aevi Genomic Medic...NASDAQ:ARDXArdelyx Inc
07/02/201912h30PR Newswire (US)Ardelyx Collaboration Partner, Kyowa Hakko Kirin, Announces Initiation of a Phase 2 Clinical Study of Tenapanor for Hyperphos...NASDAQ:ARDXArdelyx Inc
06/02/201922h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARDXArdelyx Inc
22/01/201923h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
22/01/201923h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
22/01/201923h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
22/01/201923h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
07/01/201912h33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
16/11/201800h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
15/11/201823h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
15/11/201823h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
15/11/201823h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
13/11/201822h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
13/11/201814h30PR Newswire (US)Ardelyx Announces FDA Acceptance of the Filing of its New Drug Application for Tenapanor for the Treatment of Patients with I...NASDAQ:ARDXArdelyx Inc
07/11/201822h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARDXArdelyx Inc
07/11/201822h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
07/11/201822h05PR Newswire (US)Ardelyx Reports Third Quarter 2018 Financial Results and Recent HighlightsNASDAQ:ARDXArdelyx Inc
26/10/201819h01PR Newswire (US)Ardelyx Presents New Preclinical Data Demonstrating Synergy between Tenapanor and Sevelamer When Dosed in Combination for Ele...NASDAQ:ARDXArdelyx Inc
08/10/201814h01PR Newswire (US)Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annu...NASDAQ:ARDXArdelyx Inc
04/10/201812h30PR Newswire (US)Ardelyx to Host Its First Annual Investor Day Focused on Treatment Landscape of Renal DisordersNASDAQ:ARDXArdelyx Inc
13/09/201812h30PR Newswire (US)Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administra...NASDAQ:ARDXArdelyx Inc
29/08/201820h16PR Newswire (US)Ardelyx Announces Science Translational Medicine Publication Detailing Tenapanor's Unique Mechanism of Action Inhibiting Para...NASDAQ:ARDXArdelyx Inc
10/08/201812h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
10/08/201812h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARDXArdelyx Inc
07/08/201822h51Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Kürzlich von Ihnen besucht

LSE
0A4D
Equillium
BIT
UC837E
Unicredit Bank
BIT
I10133
IT0005589699 20241220 38...
BIT
P1H4N9
BNP Paribas Issuance
BIT
UR9Z1B
UniCredit Bank
AQSE
ZINC.GB
WisdomTree Commodity Sec...
LSE
77IB
Sg Issuer 28
COIN
NXTUSD
Nxt
TG
A283RL
Sumitomo Mitsui Trust Bank
LSE
CDM
Codemasters
BIT
P23QB9
NLBNPIT23QB9 20240726 85
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten